Public Data
51 samples
RNA-Seq of chemical modification patterns for microRNA therapeutic mimics, a case-study on miR-200c, miR-155 and miR34a
Accession: ERP157412
Published: 2024
cell line
bioactive entity
lung, lung epithelium
lung cancer
Public Data
15 samples
Evaluation of genetic inactivation of lysine deacetylases KDAC6 (HDAC6) and KDAC8 (HDAC8) versus treatment with KDAC-selective inhibitors
Accession: SRP479296
Published: 2024 in FEBS Open Bio
cell line
bioactive entity
connective tissue
fibrosarcoma
Public Data
113 samples
Modulation of the post meal PBMC transcriptomic response of shift workers after four weeks of a dietary intervention implementing a dedicated overnight fast
Accession: SRP423060
Published: 2024
primary cells
other
blood
Abdominal obesity
Public Data
24 samples
Effect of combination treatment of RNA polymerase I transcription inhibitor CX-5461 and histone deacetylase inhibitor panobinostat on gene expression in human multiple myeloma cell lines MM.1S and JJN3
Accession: SRP489926
Published: 2024
cell line
bioactive entity
blood, bone marrow
plasma cell myeloma
Public Data
10 samples
LHFPL3-AS2 lncRNA regulates epithelial polarity and its reduced expression is linked with more severe Crohn Disease
Accession: SRP405102
Published: 2024
cell line
gene, gene: crispr
colon
colon carcinoma
Public Data
9 samples
RNA-seq on primary human kidney epithelial cells with PPFIBP1 or PLEKHA1 knockdown
Accession: SRP454615
Published: 2024 in Cell Metab
primary cells
gene, gene: sirna
kidney
Public Data
12 samples
Identifying the role of MTHFD1L in prostate cancer progression from genetic analysis and experimental validation
Accession: SRP475200
Published: 2024 in Am J Cancer Res
cell line
gene, gene: sirna
prostate gland
prostate cancer
Public Data
24 samples
Rewiring of RNA methylation by the oncometabolite fumarate in renal cell carcinoma [SLAM-seq]
Accession: SRP430134
Published: 2024 in NAR Cancer
cell line
bioactive entity
kidney
hereditary leiomyomatosis and renal cell cancer, renal cell carcinoma
Public Data
2 samples
MAVI1, an Endoplasmic Reticulum-localized Microprotein, Suppresses Antiviral Innate Immune Response by Targeting MAVS on Mitochondrion
Accession: SRP413560
Published: 2024 in Sci Adv
cell line
infection
kidney
Public Data
12 samples
Rewiring of RNA methylation by the oncometabolite fumarate in renal cell carcinoma [m1A_pileup]
Accession: SRP430151
Published: 2024 in NAR Cancer
cell line
kidney
hereditary leiomyomatosis and renal cell cancer
Public Data
40 samples
Diet and multi-omics characterization in the Study of Urban and Rural Crohn Disease Evolution (SOURCE) cohort
Accession: SRP440677
Published: 2024
primary tissue
Crohn disease
Public Data
9 samples
Rewiring of RNA methylation by the oncometabolite fumarate in renal cell carcinoma [RNA-Seq]
Accession: SRP430131
Published: 2024 in NAR Cancer
cell line
kidney
hereditary leiomyomatosis and renal cell cancer
Public Data
16 samples
Targeting the SWI/SNF complexes in POU2F transcription factor driven malignancies [RNA-seq]
Accession: SRP472276
Published: 2024 in bioRxiv
cell line
bioactive entity
bone marrow, lung
plasma cell myeloma, small cell lung carcinoma
Public Data
9 samples
Transcriptomic signature of treatment with recombinant laminin 511-E8 and acetazolamide in human H69 cholangiocytes
Accession: SRP414828
Published: 2024 in Front Immunol
cell line
bioactive entity
bile duct
small cell lung carcinoma
Public Data
24 samples
Deciphering the Dose-Dependent Effects of Thymoquinone on Transcriptomic Changes and Cellular Proliferation in Glio-blastoma
Accession: SRP489873
Published: 2024
cell line
bioactive entity
brain
glioblastoma